Autoinjectors Market Size- By Application, By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
세계 오토인젝터 시장 규모는 2033년까지 16.34%의 CAGR로 418억 2,000만 달러 규모로 성장할 것으로 예상됩니다.
오토인젝터 시장은 COVID-19의 혜택을 받고 있습니다. COVID-19의 유행으로 인해 자가주사가 점점 더 대중화되어 환자가 자신의 치료에 더 깊이 관여하고 통제할 수 있게 되었습니다. 오토인젝터 시장에서는 주사 속도를 높이고 치료 불안을 관리할 수 있는 첨단 기술이 부활하고 있습니다.
세계 오토인젝터 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 소개
제2장 조사 방법
제3장 주요 요약
제4장 시장 역학
- 성장 촉진요인·억제·기회·과제 분석
- COVID-19의 시장에 대한 영향
제5장 시장 변수와 전망
- SWOT 분석
- PESTEL 분석
- Porter's Five Forces 분석
- 히트맵 분석
제6장 경쟁 상황
- 제조 거점 분포·판매 지역·제품 유형
- M&A·제휴·제품 발매·협력
제7장 세계의 오토인젝터 시장 : 용도별
- 세계의 시장 규모 점유율·예측
- 아나필락시스
- 다발성 경화증
- 류마티스 관절염
- 기타
제8장 세계의 오토인젝터 시장 : 유형별
- 세계의 시장 규모 점유율·예측
- 일회용 오토인젝터
- 재사용 가능 오토인젝터
제9장 세계의 오토인젝터 시장 : 최종사용자별
- 세계의 시장 규모 점유율·예측
- 재택 케어
- 병원·진료소
- 기타
제10장 세계의 오토인젝터 시장 예측
제11장 세계의 오토인젝터 시장 : 용도별
제12장 세계의 오토인젝터 시장 : 유형별
제13장 세계의 오토인젝터 시장 : 최종사용자별
제14장 세계의 오토인젝터 시장 : 지역별
제15장 기업 개요
- Abbie
- Amgen
- Bayer
- Becton
- Dickinson and Company
- Eli Lilly
- Novartis
- Teva Pharmaceuticals
- Ypsomed
- 기타
제15장 약어 리스트
제16장 참고 링크
제17장 결론
제18장 조사 범위
ksm
Autoinjectors Market Introduction and Overview
According to SPER market research, 'Autoinjectors Market Size - By Application, By Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Autoinjectors Market is predicted to reach USD 41.82 billion by 2033 with CAGR of 16.34%.
One dose of medication, mostly life-saving medications, is administered via autoinjectors. The main purpose of these spring-loaded autoinjectors is to apply drugs in a secure and safe manner. The auto-injector delivery system has revolutionized the industry and changed people's perceptions. Human growth hormones are administered using self-injectors; insulin was recently supplanted by highly developed autoinjectors. Spring-loaded, single-use, disposable syringes (prefilled syringes) are the most common type of autoinjector.
There has been a noticeable decrease in patients postponing seeking therapy and treatment once the limits were changed. The market for autoinjectors has benefited from COVID-19. Self-injections have become increasingly popular as a result of the COVID-19 pandemic, giving patients greater involvement and control over their care. The market for autoinjectors has seen a resurgence of advanced technologies because they enable improved injection speed and the management of treatment anxiety.
Scope of the Report:
Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Application, By Type, By End User
Regions covered North America, Europe, Asia - Pacific, Middle East, and Africa, and South America
Companies Covered Abbie, Amgen, AstraZeneca, Bayer, Becton, Dickinson and Company, Biogen, Eli Lilly, Novartis, Teva Pharmaceuticals, and Ypsomed and various others.
Global Autoinjectors Market Segmentation:
By Application: Based on the Application, Global Autoinjectors Market is segmented as; Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others.
By Type: Based on the Type, Global Autoinjectors Market is segmented as; Disposable Autoinjectors and Reusable Autoinjectors.
By End-User: Based on the End-User, Global Autoinjectors Market is segmented as; Home Care Settings, Hospital and Clinics, and Others.
Table of Contents
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 4.2. COVID-19 Impact of the Global Autoinjectors Market
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Autoinjectors Market Manufacturing Base Distribution, Sales Area, Type, Application
- 6.2. Mergers & Acquisitions, Partnerships, Type Launch, and Collaboration in Global Autoinjectors Market
7. Global Autoinjectors Market, By Application, 2020-2033 (USD Million)
- 7.1. Global Autoinjectors Market Value Share and Forecast, By Application, 2024-2033
- 7.2. Anaphylaxis
- 7.3. Multiple Sclerosis
- 7.4. Rheumatoid Arthritis
- 7.5. Others
8. Global Autoinjectors Market, By Type, 2020-2033 (USD Million)
- 8.1. Global Autoinjectors Market Value Share and Forecast, By Type, 2024-2033
- 8.2. Disposable Autoinjectors
- 8.3. Reusable Autoinjectors
9. Global Autoinjectors Market, By End User, 2020-2033 (USD Million)
- 9.1. Global Autoinjectors Market Value Share and Forecast, By Type, 2024-2033
- 9.2. Home Care Settings
- 9.3. Hospital and Clinics
- 9.4. Others
10. Global Autoinjectors Market Forecast, 2020-2033 (USD Million)
- 10.1. Global Autoinjectors Market Size and Market Share
11. Global Autoinjectors Market, By Application, 2020-2033 (USD Million)
- 11.1. Global Autoinjectors Market Size and Market Share By Application (2020-2026)
- 11.2. Global Autoinjectors Market Size and Market Share By Application (2027-2033)
12. Global Autoinjectors Market, By Type, 2020-2033 (USD Million)
- 12.1. Global Autoinjectors Market Size and Market Share By Type (2020-2026)
- 12.2. Global Autoinjectors Market Size and Market Share By Type (2027-2033)
13. Global Autoinjectors Market, By End User, 2020-2033 (USD Million)
- 13.1. Global Autoinjectors Market Size and Market Share By End User (2020-2026)
- 13.2. Global Autoinjectors Market Size and Market Share By End User (2027-2033)
14. Global Autoinjectors Market, By Region, 2020-2033 (USD Million)
- 14.1. Global Autoinjectors Market Size and Market Share By Region (2020-2026)
- 14.2. Global Autoinjectors Market Size and Market Share By Region (2027-2033)
- 14.2.1. Africa
- 14.2.2. Asia - Pacific
- 14.2.3. Europe
- 14.2.4. Middle East
- 14.2.5. North America
- 14.2.6. South America
15. Company Profile
- 15.1. Abbie
- 15.1.1. Company details
- 15.1.2. Financial outlook
- 15.1.3. Type summary
- 15.1.4. Recent developments
- 15.2. Amgen
- 15.2.1. Company details
- 15.2.2. Financial outlook
- 15.2.3. Type summary
- 15.2.4. Recent developments
- 15.3. Bayer
- 15.3.1. Company details
- 15.3.2. Financial outlook
- 15.3.3. Type summary
- 15.3.4. Recent developments
- 15.4. Becton
- 15.4.1. Company details
- 15.4.2. Financial outlook
- 15.4.3. Type summary
- 15.4.4. Recent developments
- 15.5. Dickinson and Company
- 15.5.1. Company details
- 15.5.2. Financial outlook
- 15.5.3. Type summary
- 15.5.4. Recent developments
- 15.6. Eli Lilly
- 15.6.1. Company details
- 15.6.2. Financial outlook
- 15.6.3. Type summary
- 15.6.4. Recent developments
- 15.7. Novartis
- 15.7.1. Company details
- 15.7.2. Financial outlook
- 15.7.3. Type summary
- 15.7.4. Recent developments
- 15.8. Teva Pharmaceuticals
- 15.8.1. Company details
- 15.8.2. Financial outlook
- 15.8.3. Type summary
- 15.8.4. Recent developments
- 15.9. Ypsomed
- 15.9.1. Company details
- 15.9.2. Financial outlook
- 15.9.3. Type summary
- 15.9.4. Recent developments
- 15.10. Others
15 List of Abbreviations
16 Reference Links
17 Conclusion
18 Research Scope
